Intransparent with blackout periods - Recensione dipendente - Dipendente anonimo presso BeOne

2,0
17 feb 2024
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good product. Good pipeline. Fair base compensation.

Svantaggi

Totally intransparent timing for blackout periods. And very, very long blackout periods. After quarter results are announced, there might be 2-3 weeks to trade, then it is blackout again. Total trading days during the year might be 60 or so. This makes it nearly impossible to sell shares on up days, which invariably occur only during very, very long blackout periods. They keep touting some special plan that you can set up during an open window, but it requires approvals and it also means you cannot maximize because you pick a limit price ahead of time. You have to pre-pick a value at which you want to sell and then hope the price goes that high but not higher, otherwise you have just sold for less than you otherwise could have. It is really annoying because LTIs are marketed during recruitment process and account for a big part of the total comp package.

Esplora altre recensioni su BeOne

5,0
24 apr 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Svantaggi

Fast timelines and global expansion may translate into heavy workload and urgency

3,0
5 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good wprk tee lunch and free commute

Svantaggi

Bad work but bad commute to work

Vedi recensioni per: Utile|Valutazione|Data|Tutto